Evidence map›Paper›PMID 27814765›Full record

ArticleMalaria journal2016

Antibody responses to the full-length VAR2CSA and its DBL domains in Cameroonian children and teenagers.

Barriere A Y Fodjo, Njika Atemnkeng, Livo Esemu, Emile K Yuosembom, Isabella A Quakyi, Viviane H M Tchinda, Joseph Smith, Ali Salanti, Jude Bigoga, Diane W Taylor and 2 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Stringent Selection of KnobbyMicroorganisms · 2020
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 4 countries.

Barriere A Y FodjoDepartment of Biochemistry, Faculty of Medicine and Biomedical Research, Biotechnology Centre, University of Yaoundé 1, Yaounde, Cameroon. fodjoyetgang@gmail.com.
Njika AtemnkengDepartment of Biochemistry, Faculty of Medicine and Biomedical Research, Biotechnology Centre, University of Yaoundé 1, Yaounde, Cameroon.
Livo EsemuDepartment of Biochemistry, Faculty of Medicine and Biomedical Research, Biotechnology Centre, University of Yaoundé 1, Yaounde, Cameroon.
Emile K YuosembomDepartment of Biochemistry, Faculty of Medicine and Biomedical Research, Biotechnology Centre, University of Yaoundé 1, Yaounde, Cameroon.
Isabella A QuakyiSchool of Public Health, College of Health Sciences, University of Ghana, Legon, Ghana.
Viviane H M TchindaDepartment of Biochemistry, Faculty of Medicine and Biomedical Research, Biotechnology Centre, University of Yaoundé 1, Yaounde, Cameroon.
Joseph SmithSeattle Biomedical Research Institute, Seattle, WA, 98109, USA.
Ali SalantiDepartment of Immunology and Microbiology, Centre for Medical Parasitology, University of Copenhagen, Copenhagen, Denmark.
Jude BigogaDepartment of Biochemistry, Faculty of Medicine and Biomedical Research, Biotechnology Centre, University of Yaoundé 1, Yaounde, Cameroon.
Diane W TaylorDepartment of Tropical Medicine, Medical Microbiology and Pharmacology, University of Hawaii at Manoa, John A Burns School of Medicine, 651 Ilalo Street, BSB 320, Honolulu, Hawaii, 96813, USA.
Rose G F LekeDepartment of Biochemistry, Faculty of Medicine and Biomedical Research, Biotechnology Centre, University of Yaoundé 1, Yaounde, Cameroon.
Anna BabakhanyanDepartment of Tropical Medicine, Medical Microbiology and Pharmacology, University of Hawaii at Manoa, John A Burns School of Medicine, 651 Ilalo Street, BSB 320, Honolulu, Hawaii, 96813, USA.
Université de Yaoundé I · CMUniversity of Hawaiʻi at Mānoa · USCenter for Infectious Disease Research · USUniversity of Copenhagen · DKUniversity of Ghana · GH

Funding

Northern/Pacific Universities Global Health Research Training ConsortiumR25TW009345 · FIC · UNIVERSITY OF WASHINGTON · PI KOLARS, JOSEPH C., NERURKAR, VIVEK RAMCHANDRA · 2012 to 2016
$5.9M
Malarial Immunity in Pregnant Cameroonian WomenR01AI071160 · NIAID · UNIVERSITY OF HAWAII AT MANOA · PI TAYLOR, DIANE WALLACE · 2007 to 2011
$3.0M
TH2 BIAS EFFECT ON MALARIAL IMMUNITY IN CAMEROONU01AI043888 · NIAID · GEORGETOWN UNIVERSITY · PI TAYLOR, DIANE WALLACE · 1998 to 2002
$2.7M
Training of Cameroonian Scientists in Research on MalariaD43TW009074 · FIC · UNIVERSITY OF HAWAII AT MANOA · PI NERURKAR, VIVEK RAMCHANDRA · 2011 to 2015
$978k
TRAINING OF CAMEROONIAN SCIENTISTSD43TW001264 · FIC · GEORGETOWN UNIVERSITY · PI TAYLOR, DIANE WALLACE · 1999 to 2003
$783k
FIC NIH HHS D43 TW001264FIC NIH HHS D43 TW009074FIC NIH HHS R25 TW009345NIAID NIH HHS R01 AI071160NIAID NIH HHS U01 AI043888
6 · The paper itself

Abstract

backgroundAntigenic variation of Plasmodium falciparum erythrocyte membrane protein 1 is a key parasite mechanism for immune evasion and parasite survival. It is assumed that the number of parasites expressing the same var gene must reach high enough numbers before the host can produce detectable levels of antibodies (Ab) to the variant. VAR2CSA is a protein coded for by one of 60 var genes that is expressed on the surface of infected erythrocytes (IE) and mediates IE binding to the placenta. The idea that Ab to VAR2CSA are pregnancy-associated was challenged when VAR2CSA-specific Ab were reported in children and men. However, the frequency and conditions under which Ab to VAR2CSA are produced outside pregnancy is unclear. This study sought to determine frequency, specificity and level of Ab to VAR2CSA produced in children and whether children with hyperparasitaemia and severe malaria are more likely to produce Ab to VAR2CSA compared to healthy children.

methodsAntibody responses to a panel of recombinant proteins consisting of multiple VAR2CSA Duffy-binding-like domains (DBL) and full-length VAR2CSA (FV2) were characterized in 193 1-15 year old children from rural Cameroonian villages and 160 children with severe malaria from the city.

resultsLow Ab levels to VAR2CSA were detected in children; however, Ab levels to FV2 in teenagers were rare. Children preferentially recognized DBL2 (56-70%) and DBL4 (50-60%), while multigravidae produced high levels of IgG to DBL3, DBL5 and FV2. Sixty-seven percent of teenage girls (n = 16/24) recognized ID1-ID2a region of VAR2CSA. Children with severe forms of malaria had significantly higher IgG to merozoite antigens (all p < 0.05), but not to VAR2CSA (all p > 0.05) when compared to the healthy children.

conclusionThe study suggests that children, including teenage girls acquire Ab to VAR2CSA domains and FV2, but Ab levels are much lower than those needed to protect women from placental infections and repertoire of Ab responses to DBL domains is different from those in pregnant women. Interestingly, children with severe malaria did not have higher Ab levels to VAR2CSA compared to healthy children.

Indexed as

Antibody FormationAdolescentAntibodies, ProtozoanAntigens, ProtozoanCameroonChildChild, PreschoolCross-Sectional StudiesFemaleHumansInfantLongitudinal StudiesMalePlasmodium falciparumAntibodies, ProtozoanAntigens, ProtozoanVAR2CSA protein, Plasmodium falciparumAntibodyChildrenMalariaVAR2CSA

Identifiers

PMID27814765
PMCPMC5097422
OpenAlexW2547263014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.